These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2278640)

  • 1. Endometrial carcinoma: current concepts and future perspectives.
    Lindahl B
    Crit Rev Oncol Hematol; 1990; 10(4):315-26. PubMed ID: 2278640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of steroid receptor concentration and flow cytometrical DNA measurements in stage I-II endometrial carcinoma.
    Lindahl B; Alm P; Fernö M; Killander D; Långström E; Norgren A; Tropé C
    Acta Oncol; 1989; 28(4):595-9. PubMed ID: 2789839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma.
    Iversen OE
    Am J Obstet Gynecol; 1986 Oct; 155(4):770-6. PubMed ID: 3766632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative prognostic significance of DNA flow cytometry and histologic grading in endometrial carcinoma.
    Quillamor RM; Furlong JW; Hoschner JA; Wynn RM
    Gynecol Obstet Invest; 1988; 26(4):332-7. PubMed ID: 3229666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of and indications for radiotherapy in endometrial carcinoma].
    Kucera H
    Strahlenther Onkol; 1991 Jul; 167(7):381-6. PubMed ID: 1858012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of flow cytometrical DNA measurements in stage I-II endometrial carcinoma: correlations with steroid receptor concentration, tumor myometrial invasion, and degree of differentiation.
    Lindahl B; Alm P; Fernö M; Killander D; Långström E; Norgren A; Trope C
    Anticancer Res; 1987; 7(4B):791-7. PubMed ID: 3674764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
    Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
    J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in endometrial cancer.
    Creasman WT; Eddy GL
    Semin Surg Oncol; 1990; 6(6):339-42. PubMed ID: 2263809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flow cytometric DNA analysis of uterine endometrial carcinoma].
    Izumi S; Yamaoka K; Arai H; Watanabe T; Tsutsui F; Tamura S; Nozawa S; Kurihara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):722-8. PubMed ID: 1890350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometrical DNA- and clinical parameters in the prediction of prognosis in stage I-II endometrial carcinoma.
    Lindahl B; Gullberg B
    Anticancer Res; 1991; 11(1):397-401. PubMed ID: 2018376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic significance of cell kinetic parameters of endometrial cancer].
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Abel U; Heep J; von Minckwitz G
    Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):787-92. PubMed ID: 2806852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of patients with uterine serous carcinoma using the revised FIGO staging system.
    Seward S; Ali-Fehmi R; Munkarah AR; Semaan A; Al-Wahab ZR; Elshaikh MA; Cote ML; Morris RT; Bandyopadhyay S
    Int J Gynecol Cancer; 2012 Mar; 22(3):452-6. PubMed ID: 22274544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA content as a prognostic factor in endometrial carcinoma.
    Newbury R; Schuerch C; Goodspeed N; Fanning J; Glidewell O; Evans M
    Obstet Gynecol; 1990 Aug; 76(2):251-7. PubMed ID: 2371030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups.
    Mittal KR; Schwartz PE; Barwick KW
    Cancer; 1988 Feb; 61(3):538-45. PubMed ID: 3338021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Degree of DNA ploidy and steroid hormone receptors as prognostic factors in endometrial carcinoma].
    Köhler U; Martin R; Krug H; Bilek K
    Zentralbl Gynakol; 1991; 113(20):1086-95. PubMed ID: 1746194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined surgery and radiation in endometrial carcinoma: an analysis of prognostic factors.
    Nori D; Hilaris BS; Tome M; Lewis JL; Birnbaum S; Fuks Z
    Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):489-97. PubMed ID: 3104248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: an important prognostic indicator.
    Rosenberg P; Wingren S; Simonsen E; Stàl O; Risberg B; Nordenskjöld B
    Gynecol Oncol; 1989 Oct; 35(1):50-4. PubMed ID: 2792902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations.
    Lindahl B; Alm P; Killander D; Långström E; Tropé C
    Anticancer Res; 1987; 7(4B):781-9. PubMed ID: 3674763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.